
Sun Pharmaceutical Industries shares plunged nearly 6 per cent in late morning trade on Tuesday after the pharma company posted…
Country’s largest drug maker Sun Pharmaceutical Industries today reported a consolidated net profit of Rs 1,713.69 crore for the fourth…
Driven by a sharp rally in the stock market last week, the combined market valuation of top- 10 most valued…
Sun Pharma shares rallied after it said that the umbrella pact and transaction agreements signed with Daiichi Sankyo and its…
RespiTrack seeks to enable doctors to track treatment progress of their patients and increase compliance to medication
The combined market valuation of nine of the top 10 most valued Indian companies diminished by Rs 47,932.59 crore last…
ICGEB will provide the technical know-how and pre-clinical expertise and Sun Pharma to develop this drug with appropriate pre-clinical &…
The IL-23p19 Therapeutic Antibody meets primary endpoints in both placebo-controlled studies and secondary endpoint in active-comparator etanercept arm
Partnership to demonstrate malaria elimination in over 1,200 villages of MP’s Mandla district by FY21
First NSAID approved for prevention of ocular pain in patients undergoing cataract surgery
Orchid Pharma shares closed 11.10 per cent up at Rs 43.05 after the company received an Establishment inspection report (EIR)…
According to the agreements entered into between the parties, a wholly-owned subsidiary of Sun Pharma will acquire the portfolio consisting…
Acquires 14 prescription brands Sun Pharma has acquired 14 established prescription brands from Novartis in Japan. According to the agreements…
Under the agreement, Sun Pharma will promote and distribute dapagliflozin under the brand name ‘Oxra’
Strong performance of Taro was the key contributor during the quarter. Higher other income and lower tax rate resulted in…
The drug major had posted a net profit of Rs 395.33 crore during the same period of previous fiscal.
Sun Pharmaceutical shares gained over 2 per cent on Wednesday after the company and its subsidiaries launched Imatinib Mesylate Tablets…
The combined market valuation of top 10 most valued Indian companies advanced by a whopping Rs 1,02,667 crore last week,…